Blog
EQS-Adhoc: HelloFresh SE expects to have achieved highest ever quarterly adjusted EBITDA (“AEBITDA”) in Q2 2023, materially above market expectations
EQS-Adhoc: HelloFresh SE expects to have achieved highest ever quarterly adjusted EBITDA (“AEBITDA”) in Q2 2023, materially above market expectations
EQS-Adhoc: Daimler Truck Holding AG: Preliminary results for Q2 2023 above expectations
EQS-Adhoc: Daimler Truck Holding AG: Preliminary results for Q2 2023 above expectations
EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figures
EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figures
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Fix Price Group PLC: Notification of PDMR transaction
Fix Price Group PLC: Notification of PDMR transaction
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Hudson And The House Of LR&C Open First Airport Location For The Company
Hudson And The House Of LR&C Open First Airport Location For The Company
EQS-News: Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority
EQS-News: Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Director/PDMR Shareholding
Director/PDMR Shareholding
EQS-News: CPI PROPERTY GROUP – Moody’s Baa3 Rating Affirmed
EQS-News: CPI PROPERTY GROUP – Moody’s Baa3 Rating Affirmed
EQS-News: q.beyond and Tchibo agree new digital partnership and extensions to contracts
EQS-News: q.beyond and Tchibo agree new digital partnership and extensions to contracts
EQS-News: Enapter AG supports Tokyo Gas in implementing Japan’s hydrogen strategy transition
EQS-News: Enapter AG supports Tokyo Gas in implementing Japan’s hydrogen strategy transition
EQS-News: Aareal Bank – 100 years serving the property industry
EQS-News: Aareal Bank – 100 years serving the property industry
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Biophytis Announces $3.8 Million Registered Direct Offering
Biophytis Announces $3.8 Million Registered Direct Offering
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
EQS-News: Hypoport SE: further slight rise in the volume of mortgage finance transactions per working day
EQS-News: Hypoport SE: further slight rise in the volume of mortgage finance transactions per working day
EQS-Adhoc: STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR
EQS-Adhoc: STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR
EQS-Adhoc: cyan AG: Resolution to rescind and implement a capital increase
EQS-Adhoc: cyan AG: Resolution to rescind and implement a capital increase
Chelverton UK Dividend Trust plc: Holding(s) in Company*
Chelverton UK Dividend Trust plc: Holding(s) in Company*


